Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The use of IL-17 and IL-23 inhibitors in Swedish clinical practice: a register-based analysis
The Swedish Institute of Health Economics (IHE), Lund, Sweden.
The Swedish Institute of Health Economics (IHE), Lund, Sweden.
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Dermatology and Venerology.ORCID iD: 0000-0002-3858-8474
2023 (English)In: Dermatology, ISSN 1018-8665, E-ISSN 1421-9832, Vol. 239, no 2, p. 262-266Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Interleukin (IL) inhibitors have made completely cleared skin achievable for many patients with moderate to severe psoriasis in clinical trial settings. Few observational studies assess treatment response in accordance with treatment goals in guidelines.

OBJECTIVES: The aim of the study was to analyze the treatment response of IL-17/IL-23 inhibitors in clinical practice and the proportions of patients that reach the treatment target of the Psoriasis Area and Severity Index (PASI) < 3 and the Dermatology Life Quality Index (DLQI) ≤5.

METHODS: A longitudinal, observational study based on the Swedish National Registry for Systemic Treatment of Psoriasis, PsoReg. Patients using IL-17/IL-23 inhibitors with assessments of PASI, DLQI, and EQ-5D before (maximum 6 months) and after (3-12 months) initiation of IL-17/IL-23 were included.

RESULTS: In total, 333 patients using IL-17/IL-23 inhibitors were included. Eighty percent (n = 266) received IL-17 inhibitors, and 20% (n = 67) received IL-23 inhibitors. Sixty-six percent of patients reached both PASI <3 and DLQI ≤5, 23% reached one target, and 11% reached none. The mean (SD) PASI, DLQI, and EQ-5D improvements were 6.75 (6.99), 7.14 (7.97), and 0.126 (0.296), respectively. There was no statistically significant difference in outcomes between IL-17 and IL-23 inhibitor treatment groups.

CONCLUSIONS: IL-17/IL-23 inhibitors are effective in clinical practice, but there is still an unmet therapeutic need in moderate to severe psoriasis.

Place, publisher, year, edition, pages
S. Karger, 2023. Vol. 239, no 2, p. 262-266
Keywords [en]
DLQI, EQ-5D, Interleukin inhibitors, PASI, Psoriasis
National Category
Dermatology and Venereal Diseases
Research subject
Dermatology and Venerology
Identifiers
URN: urn:nbn:se:umu:diva-201766DOI: 10.1159/000528007ISI: 000898408100001PubMedID: 36516805Scopus ID: 2-s2.0-85145581075OAI: oai:DiVA.org:umu-201766DiVA, id: diva2:1720009
Available from: 2022-12-16 Created: 2022-12-16 Last updated: 2023-07-14Bibliographically approved

Open Access in DiVA

fulltext(160 kB)44 downloads
File information
File name FULLTEXT02.pdfFile size 160 kBChecksum SHA-512
afd61f62b1309639152144e08bec8d7764fe3f5712f3b5dacab99b6f5e9042b08cb126ef60e1464f4bcee7d0939b45cbebd44bd3c8a26c951149fa6a8937cfd3
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Schmitt-Egenolf, Marcus

Search in DiVA

By author/editor
Schmitt-Egenolf, Marcus
By organisation
Dermatology and Venerology
In the same journal
Dermatology
Dermatology and Venereal Diseases

Search outside of DiVA

GoogleGoogle Scholar
Total: 107 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 297 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf